IMMUNOGLOBULIN G, ANTI-(HUMAN CALCITONIN GENE-RELATED PEPTIDE RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER
Migraine Associated Vertigo
Stanford Universitymonoclonal_antibodyPhase 4 / ApprovedActive
B
62/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 81/ 100
Competitive context
9 Active assets in the Migraine Associated Vertigo cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Eptinezumab Stanford University | Phase 4 | B |
Atogepant Stanford University | Phase 4 | B |
Galcanezumab Stanford University | Phase 4 | B |
Amitriptyline Stanford University | Phase 4 | B |
VERAPAMIL SLOW RELEASE Stanford University | Phase 4 | B |
View all 9 →
Same molecule, other indications
IMMUNOGLOBULIN G, ANTI-(HUMAN CALCITONIN GENE-RELATED PEPTIDE RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →